Arthritis drug ‘tocilizumab’ improves survival in critically ill COVID-19 patients: Study
Boston: Anti-inflammatory drug ‘tocilizumab’ has been shown to reduce mortality by 30 per cent among critically ill COVID-19 patients. This ...
Read moreBoston: Anti-inflammatory drug ‘tocilizumab’ has been shown to reduce mortality by 30 per cent among critically ill COVID-19 patients. This ...
Read moreNew Delhi: Anti-viral drug ‘remdesivir’ and ‘tocilizumab’, an immunomodulator, are being considered for ‘restricted use’ on severely ill COVID-19 patients ...
Read moreBeijing: An integrated treatment of western drugs and traditional Chinese medicine (TCM) has helped most of the over 50,000 coronavirus ...
Read more
The Supreme Court ruling on 8 April declaring as erroneous and illegal the action of Tamil Nadu Governor RN Ravi,...
Read moreOf all the problems that India faces in its neighbourhood, the most pressing one seems to be emerging from Bangladesh...
Read moreOne American – a poet (TS Eliot) – wrote many years ago, “April is the cruellest month.” Another American –...
Read moreHow do trade wars end? To answer that, we have to ask ourselves, how do wars end? The answer is...
Read more